Sign in Create account
Sign in and upgrade to a paid plan to export financials as CSV.

Vivo Bio Tech Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: VIVOBIOT BSE: 511509
₹17.06
▲ 0.01 (0.06%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
29/100
Weak
Valuation
100/100
Undervalued
Momentum
43/100
Neutral

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹38 Cr
PE (TTM)
Data unavailable.
Price to Book
0.4
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-3 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-89.47%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-140.29%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
10.89%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-86.60%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
13.85%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
0.94
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.72
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
1.61
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
1.30%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
11.12%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
16.55%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
-1.11%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
7.20%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
-2.08%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.72)
  • No Return on equity is 15% or more (-2.1%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 2 met
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 2 met
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 4 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.1%
Low 16.1100 · High 17.2400
1W return
2.3%
Low 15.5100 · High 17.4400
1M return
-8.0%
Low 15.5100 · High 19.9800
52W return
Data unavailable.
Low 15.5100 · High 20.9400
Lifetime High ₹19.6800 (Aug. 17, 2026)
Lifetime Low ₹16.0800 (Sept. 24, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish1
5D
16.8
10D
16.9
20D
17.3

Delivery and volume

Day avg. delivery
82.3%
Week avg. delivery
87.5%
Month avg. delivery
84.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

16.80
Pivot
First resistance17.50
Second resistance17.93
Third resistance18.63
First support16.37
Second support15.67
Third support15.24
Day RSI43.4
Day MFI25.1
Day MACD—
Day MACD signal—

Beta

1M0.52
3M0.33
1Y0.33
3Y0.33

Price change analysis

↓ -8.0%
Over 1 Month
LowHigh
15.5119.98
—
Over 3 Months
LowHigh
15.5120.94
—
Over 6 Months
LowHigh
15.5120.94
—
Over 1 Year
LowHigh
15.5120.94
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹14 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.0800

Ranks #157 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter30.62%

Largest holders

NameCategoryShares %Shares
ANTIQUE INFOTECH PRIVATE LIMITEDPublic11.7100%2599517
DWIGHT TECHNOLOGIES PRIVATE LIMITEDPublic8.4400%1872561
Vira Systems Private LimitedPromoter6.0600%1345000
ELITE CLASS ASSET HOLDINGS LTDPublic5.8600%1300000
MAXCELL PHONES COMMUNICATIONS INDIA PRIVATE LIMITEDPromoter5.4100%1200000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 35.43% to 30.62% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 19 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
8 Jun 2026 VEAN SMART INFRA PRIVATE LIMITED Bulk Buy 294,000 24.1200 BSE
8 Jun 2026 MORE AGRISUPPLIES & SERVICES PRIVATE LIMITED Bulk Buy 699,248 24.2800 BSE
8 Jun 2026 SHRI SHRI RESORTS PVT LTD Bulk Sell 1,000,000 24.2300 BSE
16 Sep 2025 MAHESH RATHORE Bulk Sell 108,000 38.0000 BSE
14 May 2025 MALLEMKONDA REALITIES PVT Bulk Sell 206,395 41.2000 BSE
13 May 2025 MALLEMKONDA REALITIES PVT Bulk Sell 94,307 40.2700 BSE
22 Jan 2025 SUDHIRKUMAR Bulk Buy 103,102 55.2600 BSE
22 Jan 2025 SUDHIRKUMAR Bulk Sell 103,102 56.1800 BSE
3 Jan 2025 EVERY WEAR IMPORT AND EXPORT PRIVATE LIMITED Bulk Sell 237,448 41.6100 BSE
6 Dec 2024 VEAN SMART INFRA PRIVATE LIMITED Bulk Sell 81,421 37.5100 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Sunshine Factors & Exports Ltd. to Vivo Bio tech Ltd.

All corporate actions →

Corporate Announcements

All 7 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Vivo Bio Tech Ltd - 511509 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Vivo Bio Tech Ltd - 511509 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Company Update Vivo Bio Tech Ltd - 511509 - Announcement under Regulation 30 (LODR)-Change in Management
25 Sep 2026 Insider Trading / SAST Vivo Bio Tech Ltd - 511509 - Closure of Trading Window
10 Sep 2026 Company Update Vivo Bio Tech Ltd - 511509 - Re-Lodgement Of Transfer Requests Of Physical Shares.
9 Sep 2026 Company Update Vivo Bio Tech Ltd - 511509 - Web Link Intimation
9 Sep 2026 Company Update Vivo Bio Tech Ltd - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (-2.1%)
  • Thin net profit margin (1.3%)
  • Tight liquidity (Current Ratio 0.94)
  • Declining profit YoY (-86.6%)

Opportunities

  • Trading below book value (PB 0.41)

Threats

  • Weak interest coverage (1.6x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Vivo Bio Tech Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.